Floatz logo

Anti-Cd30-Car-Transduced T Cells

Angioimmunoblastic T-cell Lymphoma

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCell therapyPhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

55 Active assets in the Angioimmunoblastic T-cell Lymphoma cohort.

Asset / SponsorPhaseRating
Ifosfamide
Shandong Provincial Hospital
Phase 4BBB
DEXAMETHASONE
Ou Bai, MD/PHD
Phase 2BB
Romidepsin
The Lymphoma Academic Research Organisation
Phase 3BB
PREDNISONE TABLETS
Shanghai Jiao Tong University School of Medicine
Phase 4BB
Fludarabine
National Cancer Institute (NCI)
Phase 2BB

View all 50 →

Same molecule, other indications

Anti-Cd30-Car-Transduced T Cells is also rated in:

lymphomaDormant
CC
Indicative ·
46 / 100
View asset →
leukemiaDormant
CC
Indicative ·
46 / 100
View asset →
adult T-cell leukemia/lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →